MRNA Jan 2024 150.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:52AM EDT. Market open.
Loading interactive chart…
- Yahoo Finance
Novavax does not have a forecast for U.S. orders in 2022: CEO Erck
Novavax missed Wall Street expectations but remains optimistic about the fourth quarter and 2023.
- Zacks
Novavax (NVAX) Q2 Earnings Miss, Cuts '22 Sales Guidance by Half
Novavax (NVAX) reports dismal results in second-quarter 2022. The stock dives in after-market trading after management slashes revenue guidance for 2022 by half.
- Zacks
MRNA vs. TECH: Which Stock Should Value Investors Buy Now?
MRNA vs. TECH: Which Stock Is the Better Value Option?
© 2022 Yahoo. All rights reserved.
